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Introduction 1
Positron emission tomography (PET) is a powerful molecular imaging technique that is widely used in both 2 clinical and research settings (see Heurling et al., 2017 for a recent comprehensive review). The molecular 3 targets that can be imaged using PET are only limited by the availability of radiotracers, and numerous tracers 4
have been developed to image neural metabolism, receptors, proteins and enzymes (Chen et al., 2018; Jones 5 & Rabiner, 2012) . In neuroscience, one of the most used radiotracers is [18F]-fluorodeoxyglucose (FDG-PET), 6 which provides an index of cerebral glucose metabolism. The human brain requires a constant and reliable 7
supply of glucose to satisfy its energy requirements (Kety, 1957; Sokoloff, 1960) , and 70-80% of cerebral 8 glucose metabolism is used by neurons during synaptic transmission (Harris, Jolivet, & Attwell, 2012) . Changes 9
to cerebral glucose metabolism are thought to initiate and contribute to numerous conditions, including 10 psychiatric, dementia, neurodegenerative, and ischaemic conditions ( 2017), it is considered a more direct and less confounded index of neuronal activity, compared to the more 14 widely used blood oxygenation level dependent functional magnetic resonance imaging (BOLD-fMRI) 15 response. 16
The majority of existing FDG-PET studies in the human brain have acquired 'static' images of cerebral glucose 17 metabolism. In this method, the participant rests quietly for 10-mins with their eyes opened in a darkened 18
room. The full dose is administered as a bolus over a period of seconds, and the participant then rests for a 19 further 30-mins. Following the uptake period, participants are placed in the centre of the PET scanner, and a 20
PET image is acquired, which reflects the cumulative FDG distribution over the course of the uptake and 21 scanning periods. Thus, the neuronal activity indexed by the PET image represents the cumulative average of 22 all cognitive activity over uptake and scan periods, and is not specific to cognitive activity during the course of 23 the scan. This method has provided great insight into the cerebral metabolism of the brain and neuronal 24 function. However, the temporal resolution is ~45mins, effectively yielding a static measurement in 25 comparison to cognitive processes and common experiments in neuroimaging. Due to the limited temporal 26 resolution, the method provides a non-specific index of glucose metabolism (i.e., not locked to a task or 27 cognitive process) and cannot provide measures of within-subject variability (which can lead to erroneous 28 scientific conclusions due to Simpson's Paradox 1 ; Roberts, Hach, Tippett, & Addis, 2016). Furthermore, recent 29 attempts to apply connectivity measures to FDG-PET can only measure 'connectivity' across subjects; thus, 30 differences in connectivity can only be compared between groups and cannot be calculated for individual 31
subjects. While it is debatable what exactly across-subject connectivity actually measures (Horwitz, 2003) , the 32 poor temporal resolution of the bolus FDG-PET method means that 'metabolic connectivity' cannot be used as 33 a biomarker for disease states, or to examine the source of individual variation, as has been previously 34
attempted (e.g., Yakushev, Drzezga, & Habeck, 2017) . 35
In the past 5 years, the development and wider accessibility of clinical-grade simultaneous MRI-PET scanners 36 has sparked renewed research interest in FDG-PET imaging (Chen et al., 2018) . With these developments, 37
researchers have focused on improving the temporal resolution of FDG-PET to approach the standards of 38
BOLD-fMRI (between ~0.5-2.5sec). Dynamic FDG-PET acquisitions, which are often used clinically, use the 39 bolus administration method and reconstruct the list-mode data into bins. The bolus dynamic FDG-PET 40 method offers a temporal resolution of around 100sec (e.g., Tomasi et al., 2017) ; this is clearly much improved 1 compared to static FDG-PET imaging, but is not comparable to BOLD-fMRI. Additionally, the window in which 2 brain function may be examined is limited as the blood plasma concentration of FDG diminishes. 3
To expand this experimental window, a handful of studies (e.g., Hahn proposed by Carson (2000; 1993) . In this method, which is sometimes described as 'functional FDG-PET' (FDG -6 fPET; analogous to BOLD-fMRI), the radiotracer is administered as a constant infusion over the course of the 7 entire PET scan (~90mins). The goal of the infusion protocol is to maintain a constant plasma supply of FDG to 8 track dynamic changes in glucose use across time. In a proof-of-concept study, Villien In this paper, we will describe in detail the acquisition protocol for acquiring high temporal resolution FDG-25
fPET scans using infusion only and bolus plus infusion radiotracer administration. Our protocols have been 26 developed for use in a simultaneous MRI-PET environment with a 90-95min acquisition time (see Jamadar et 27 al., 2019) . While our group's focus is the application of infusion methods for functional neuroimaging using 28 BOLD-fMRI/FDG-fPET, these methods can be applied to any FDG-fPET study regardless of whether 29 simultaneous MRI, BOLD-fMRI, computed tomography (CT) or other neuroimages are acquired. 30
Protocol 31
This protocol has been reviewed and approved by the Monash University Human Research Ethics Committee, 32
in accordance with the Australian National Statement on Ethical Conduct in Human Research (2007).
33
Procedures were developed under the guidance of an accredited Medical Physicist, Nuclear Medicine 34
Technologist (NMT) and clinical radiographer. Researchers should refer to their local experts and guidelines for 35
the administration of ionising radiation in humans. 36
In the simultaneous MRI-PET environment, this procedure requires four personnel: a radiographer (RG) to run 37 the scan, a nuclear medicine technologist (NMT) to oversee the administration of the radiotracer and 38
acquisition of blood samples, a laboratory assistant (LA) to spin blood, and a research assistant (RA) 39
responsible to oversee the experimental design and stimulus presentation. We use a commercial supplier for 40 the production of the radiotracer. We report procedures for infusion only and bolus/infusion protocols. Figure  41 1 shows the flowchart of procedures in this protocol. 42 the rate of infusion is 0.01mL/second over 95 minutes. So, in a 95min scan, participants receive 7 0.01ml * 60sec * 95mins = 57mL. 8 2.1.2. Calculate the dose that will be diluted into the administered solution (saline). In our protocol, 9
Required equipment 1
we administer a total dose of 260MBq to the participant over 95mins. Decay correct 260MBq 10 from the mid-infusion point (47.5mins) back to T0. 11
Using equation 1, solve for A0 12
At=A0.e t (1) 13
Where At is activity (MBq) at the mid-timepoint of the infusion; A0 is initial activity and is the 14 radioactive decay constant specific to the tracer. For FDG, the value of is ≈ 0.693/T1/2. T1/2 is the 15
half-life of 18 F (110minutes). 16
In our example, At=260MBq; = 0.693/110; t=-47.5, so A0=350.942MBq. 17 2.1.3. Calculate the required dose activity for the 100mL saline bag that will be used to administer the 18 dose to the participant. For a 100mL saline bag, the dilution factor is volume of saline (100mL) 19
divided by the infusion volume (57mL); i.e., 100mL/57mL = 1.754. So, the total dose required for 20 the 100mL bag is A0*dilution factor; i.e., 350.942MBq*1.754 = 615.688MBq. Add this dose to the 21 saline bag. 22 2.1.4. Prepare the radiotracer. site. Cello underpads should be placed at the end of the cannula and on any surface that blood 5 products and their containers will rest. Bins for regular waste and biohazardous waste should be 6
within easy reach of the blood collection site. 7 2.3. Prepare the infusion pump (NMT) 8 2.3.1. Set up infusion pump in scanner room on the side that will be connected to the participant. 9
Build lead bricks around the base of the pump and place the lead shield in front of the pump. 10
Connect the tubing for the infusion pump that delivers the infusion to the participant and 11
ensure the correct infusion rate has been entered. For this protocol the rate is 0.01mL/second. haemoglobin) from the baseline sample. imperative to ensure participant comfort to reduce to risk of participant drop out, or motion 35 artefact due to discomfort. 36 2.5.2. The NMT must flush the cannula to ensure it is patent with minimal resistance before 1 connecting the infusion line. Once connected the tubing can be lightly taped near the wrist. The 2 participant must be instructed to keep their arm straightened. Supports such as foam or cushions 3
are worthwhile for comfort. The NMT must also check the cannula that will be used for plasma 4 samples to ensure that blood is able to be withdrawn with minimal resistance, and extension 5
tubing to make the cannula more accessible whilst they are in the scanner is not leaking. 6 2.5.3. Once positioned in the scanner bore, the NMT must check that they have suitable access to 7 both cannulas. 8 2.5.4. The NMT should notify the radiographer and RA if there are any issues with the blood collection 9 cannula, infusion cannula or the infusion pump (e.g., occlusion, battery, extravasation) at any 10 time during the scan. collection, correct isotope are the most important) 18 3.1.3. The protocol is designed so that the PET acquisition will commence with the first MRI sequence. 19 The radiographer prepares the first MRI sequence. The radiographer starts the MRI sequence; the 20 start time of the 95-minute PET acquisition is time-locked to the start of the MRI sequence. If 21 required, the NMT should deliver the bolus at the time of PET acquisition (Figure 1) . 22
3.1.4. Start the infusion pump: 30-seconds after the start of the PET acquisition, the radiographer 23 signals to the NMT (e.g., via thumbs up sign) to start the pump. We start the infusion pump 30-24 seconds after scan start time to provide a safety buffer in case of scan failure. This also ensures 25
that the first image taken during the PET scan indexes the brain prior to radiotracer 26 administration for complete time activity curve data collection. The NMT will observe the pump 27
to ensure it has started to infuse the 18 F FDG and there is no immediate occlusion of the line. when entering the scanner room. Table 2 ) and be wearing gloves. It is preferable to have 14
3 racks set out for the samples: one for blood tubes (pre-and post-sample), another for pipetting 15
the sample, and the last for filled pipetted samples (pre-and post-counting). 16
Regularly change gloves throughout the procedure, especially when handling the counting tube. If 17
the LA has any radioactive plasma contamination on their gloves, it can be transferred to the 18 counting tube and spuriously increase the number of recorded counts of the sample. as not to disturb sample separation. Place a labelled counting tube in the rack. 23 3.3.4. Ensure the tip is securely fastened to the pipette. Have a tissue ready for any drips. Steadily 24 pipette 1000μL from the blood tube and transfer to the counting tube. 25
Place the counting tube into the well counter and count for 4-mins. 26
The counting start time should be recorded on the Record Sheet ('measurement time') for every 27 sample. At later time-points during the scan, the LA will be performing each step in rapid 28 succession to avoid a backlog of samples. 
Study-Specific Methods 32
Here, we report study-specific details for the representative results; these details are not critical to the 33 procedure and will vary across studies.
Participants & Task Design 1
Participants (n=3) underwent a simultaneous BOLD-fMRI/FDG-fPET study. The full results of the study will be 2 reported in Ward et al. (forthcoming) . As this manuscript focuses on the PET acquisition protocol, MRI results 3
are not reported here. Participants received 260MBq of [18F]-FDG over the course of a 95-min scan. 4
Participant 1 received the full dose as a bolus at the start of the scan. Participant 2 received the dose in an 5
infusion-only protocol, and participant 3 received the same dose with a hybrid 50% bolus + 50% infusion. For 6
both infusion-only and bolus/infusion protocols, infusion duration was 50-mins. 7
The task was presented in an embedded block design (Jamadar et al., 2018) . We have previously shown that 8
this design provides simultaneous contrast for task-evoked BOLD-fMRI and FDG-fPET data. Briefly, the task 9 alternated between 640sec flashing checkerboard blocks and 320sec rest blocks. This slow alternation 10 provides FDG-fPET contrast. Within the 640sec checkerboard blocks, checkerboard and rest periods alternated 11
at a rate of 20sec on/20sec off. This fast alternation, which is suited to BOLD-fMRI, will hopefully be detectible 12
with FDG-fPET with future analysis and reconstruction advances. were non-linearly normalised to MNI space using ANTs (Avants et al., 2011) . 26
We examined dynamic FDG-fPET results with bin size 16-sec. All data were reconstructed offline using Siemens 27
Syngo E11p and corrected for attenuation using pseudoCT (Burgos et al., 2014 (uncorrected), k=50 voxels. 44
Representative Results 1

Plasma Radioactivity Concentration 2
The plasma radioactivity concentration curve for each participant is given in Figure 2 . 3
The largest peak plasma radioactivity concentration (3.67kBq/cc) was obtained using the bolus method. The 4 peak occurs within the first 5-mins of the protocol (note that the first blood sample was taken at 5-mins post-5 bolus), and the concentration quickly decreases. By the end of the recording period, the plasma radioactivity 6
was 35% of the peak (1.28kBq/cc). The infusion only protocol reached maxima (2.22kBq/cc) at 50-mins, the 7 end of the infusion period. By the end of the recording period, the concentration was sustained at 68% of its 8 peak (1.52kBq/cc). Like the bolus only protocol, the bolus/infusion protocol reached its peak plasma 9 radioactivity concentration (2.77kBq/cc) within the first 5-mins. By the end of the recording period, 10 bolus/infusion concentration was at 53% of the peak (1.49kBq/cc). 11
Qualitatively, plasma radioactivity levels were sustained for the longest duration in the bolus/infusion 12 protocol. Both infusion-only and bolus/infusion protocols show an apparent reduction in radioactivity when 13
the infusion period ends (50-mins). Comparing bolus-only and bolus/infusion protocols, plasma radioactivity 14
was smaller in bolus-only vs. bolus/infusion by 40-mins post-injection. Critically, the plasma radioactivity was 15 minimally varied for a period of approximately 40 minutes in the bolus/infusion protocol. In contrast, neither 16
the infusion-only or bolus-only protocol exhibit a sustained period of consistent activity. 17
[FIGURE 2 HERE] 18
19
Image-Derived Uptake 20
Individual-level parameter maps, image-derived uptake and timecourses are shown in Figure 3 . 21 Figure 3ii shows the FDG uptake in bilateral visual cortex (BA17, 18, 19) and in a control region (dorsolateral 22
prefrontal cortex, BA 46) for the three administration protocols. Across all protocols, the largest uptake is in 23 primary visual cortex (BA17), followed by upper visual regions (BAs 18 and 19) , as expected from the task 24 design. The lowest uptake was in dorsolateral prefrontal cortex (BA46). Interestingly, for each ROI, uptake was 25 larger in the left than the right hemisphere. 26
In the bolus protocol, there is a sharp increase in signal following the bolus. The slope of the uptake is 27
relatively fast in the next 20-30 mins, but the rate of uptake reduces in the remainder of the measurement 28 period. In the bolus/infusion protocol, there is a sharp increase in uptake at the start of the scan that is of 29 smaller magnitude than in the bolus-only protocol, and the uptake continues at a comparatively faster rate for 30 the duration of the scan. By the end of the recording period, the bolus/infusion protocol shows a larger uptake 31
than the bolus only protocol, at least in the primary visual cortex (BA17). By comparison, the infusion-only 32 protocol shows low signal for the first 40-mins of the scan, and the peak uptake is substantially lower than the 33 bolus-only or bolus/infusion protocol. Uptake is fastest in the first ~50-mins of the scan, and slows for the 34 remainder of the recording period. 35
[FIGURE 3 HERE] 36 37
Parameter Maps and Timecourses 38 Figure 3i shows the individual-level T maps for the three administration protocols. Figure 3iii shows the 39 timecourse at the peak voxel for each subject. Note that for the infusion only protocol (Figure 3Biii ), the scale 40 is larger than for the bolus only and bolus/infusion protocols. Furthermore, the model could not be estimated 41
for the first rest period of the infusion only protocol, due to the very low signal; thus, the timecourse is shown 42 from the start of the first checkerboard period. 43
To visualise the task effects across time, we extracted the timecourse data for each subject, and calculated the 1 inverse of the coefficient of variation (mean/s.d.) for each block. The inverse of the coefficient of variation 2
approximates signal-to-noise ratio. As can be seen from Figure 4 , signal decreased roughly linearly across the 3 recording period for the bolus-only protocol, increased roughly linearly for the infusion-only protocol, and was 4 relatively flat for the bolus/infusion protocol. FDG-PET is a powerful imaging technology that indexes cerebral glucose metabolism. To date, the vast 8 majority of neuroscience studies using FDG-PET have used a traditional bolus administration approach, with a 9
static image resolution that represents the integral of all metabolic activity over the course of the scan (Chen 10 et al., 2018) . In this manuscript, we have described two alternative radiotracer administration protocols: the as well as the start of the stimulus presentation. Stimulus onsets and durations must be able to be locked to 17
the onset of the scan for the first-level models. In the bolus-only protocol, the bolus should be delivered at the 18 beginning of the PET acquisition to capture the peak signal ( Figure 4 ). In the infusion-only protocol, the 19
beginning of the infusion should be locked to the PET acquisition, to ensure accurate modelling of the uptake 20
at the first-level. In the bolus/infusion protocol, the bolus should be time-locked to the PET acquisition, with 21
the infusion starting at a known, short period, after the bolus. In order for the procedures to flow correctly 22 within this short time period, each of the staff members (NMT, radiographer, research assistant) should be 23
adequately prepared prior to the start of the scan (Figure 1 ). Dress-rehearsals are recommended to 24 choreograph the timing of this critical stage. 25
To date, we have tested approximately 60 subjects using one of these protocols (the largest number using the 26 infusion-only protocol). We have found that the likeliest cause of subject attrition or acquisition failure are 27 due to: 28 (A) being unable to cannulate the participant due to difficulty finding veins -to address this, we 29 ask all participants to drink at least 2 glasses of water before the scan. If only one cannula can be 30 achieved, we forego blood sampling for that participant. 31 (B) Participants being unable to complete the scan. Unlike MRI, the PET acquisition cannot be 32 paused then restarted. The most common causes of this are due to toilet breaks and difficulty with 33 thermal regulation. Participants have reported that the requirement to consume water before the 34 scan increases the need to urinate, thus all participants are required to use the bathroom prior to 35
scanning. Participants have also reported that the infusion of the tracer leaves them feeling very 36
cold -and the shivering reflex is triggered in some people. We address this by using a disposable 37 quilt for all participants during the scan. 38
39
Results were shown at the individual subject level for the three administration protocols. As expected, the 40 blood plasma radioactivity concentration (Figure 2 ) had the largest peak for the bolus-only protocol, but the 41 most sustained radioactivity in the bolus/infusion protocol. The plasma concentration was lowest for the 42 infusion-only protocol; and for both infusion-only and bolus/infusion, the concentration decreased at the time 43
the infusion ceased. Image-derived uptake across the four bilateral ROIs (Figure 3ii ) was consistent with the 44 plasma-based measures, with largest uptake evident in the primary visual cortex, and smallest in the 45 dorsolateral prefrontal cortex, as expected. Qualitatively, rate of uptake was largest for the longest period of 1 time in the bolus/infusion protocol, and smallest in the infusion-only protocol. It is possible that the infusion-2 only protocol would yield better results in a longer experiment (>50mins) however this would likely increase 3 the rate of participant attrition. 4
In the first-level models, model error was much greater in the infusion-only protocol compared to the bolus-5
only and bolus/infusion protocols (Figure 3iii ). Signal-to-noise during the task periods ( Figure 4 ) confirmed that 6
the most sustained signal across the recording period was obtained using the bolus/infusion protocol. 7
In summary, we present alternative methods of FDG radiotracer administration for high-temporal resolution 8
FDG-PET, with a resolution of 16sec. This temporal resolution is substantially improved over current standards 9
in the literature ( 
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